{"title":"干细胞治疗中风的现状与展望","authors":"D.M. Martínez-Garza , O.G. Cantú-Rodríguez , J.C. Jaime-Pérez , C.H. Gutiérrez-Aguirre , J.F. Góngora-Rivera , D. Gómez-Almaguer","doi":"10.1016/j.rmu.2016.07.005","DOIUrl":null,"url":null,"abstract":"<div><p>Stroke represents a public health enemy. Currently, and in spite of multiple clinical trials, thrombolysis remains as the only approved therapy. Most preclinical trials and animal trials employing stem cell-based therapies have shown very promising evidence of benefits. The aim of this review is to provide a landscape of what has been done in human clinical trials, and what are the possible ways that stem cell therapy may enhance functional recovery in stroke patients.</p></div>","PeriodicalId":34640,"journal":{"name":"Medicina Universitaria","volume":"18 72","pages":"Pages 169-180"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rmu.2016.07.005","citationCount":"10","resultStr":"{\"title\":\"Current state and perspectives of stem cell therapy for stroke\",\"authors\":\"D.M. Martínez-Garza , O.G. Cantú-Rodríguez , J.C. Jaime-Pérez , C.H. Gutiérrez-Aguirre , J.F. Góngora-Rivera , D. Gómez-Almaguer\",\"doi\":\"10.1016/j.rmu.2016.07.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Stroke represents a public health enemy. Currently, and in spite of multiple clinical trials, thrombolysis remains as the only approved therapy. Most preclinical trials and animal trials employing stem cell-based therapies have shown very promising evidence of benefits. The aim of this review is to provide a landscape of what has been done in human clinical trials, and what are the possible ways that stem cell therapy may enhance functional recovery in stroke patients.</p></div>\",\"PeriodicalId\":34640,\"journal\":{\"name\":\"Medicina Universitaria\",\"volume\":\"18 72\",\"pages\":\"Pages 169-180\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rmu.2016.07.005\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina Universitaria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665579616300710\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Universitaria","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665579616300710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Current state and perspectives of stem cell therapy for stroke
Stroke represents a public health enemy. Currently, and in spite of multiple clinical trials, thrombolysis remains as the only approved therapy. Most preclinical trials and animal trials employing stem cell-based therapies have shown very promising evidence of benefits. The aim of this review is to provide a landscape of what has been done in human clinical trials, and what are the possible ways that stem cell therapy may enhance functional recovery in stroke patients.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
